SCHEMBL6061007

SCHEMBL6061007

CCOP(=O)(OCC)C(C)c1cccnc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KCNN4 O15554 3/20 0.44
KCNA5 P22460 3/20 0.44
NPC1 O15118 1/20 0.43
MAPT P10636 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 3/20 0.41
CFTR P13569 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
GOPC Q9HD26 1/20 0.41
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9602498 0.81 KDM4E (0.46) POLBLMNAL3MBTL1MAPTALDH1A1
SCHEMBL1542688 0.81 POLB (0.66) POLBLMNASMN1; SMN2MAPTALDH1A1
SCHEMBL8824634 0.79 POLB (0.55) POLBLMNASMN1; SMN2L3MBTL1KCNN4
SCHEMBL9224803 0.77 POLB (0.43) POLBLMNASMN1; SMN2L3MBTL1KCNN4
SCHEMBL18307753 0.76 FDPS (0.43) POLBLMNAL3MBTL1ALDH1A1
SCHEMBL9228203 0.76 POLB (0.42) POLBLMNASMN1; SMN2L3MBTL1KCNN4
SCHEMBL28562456 0.75 POLB (0.40) POLBLMNAMAPTALDH1A1KDM4E
SCHEMBL6060892 0.75 FDPS (0.60) POLBLMNAL3MBTL1ALDH1A1
SCHEMBL8831743 0.75 POLB (0.38) POLBLMNASMN1; SMN2L3MBTL1KCNN4
SCHEMBL31482560 0.75 KCNA5 (0.47) KCNN4KCNA5NPC1MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482953-A4 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES ILEX PRODUCTS INC (US) 2006-12-13 EP disclosed
US-20050124581-A1 Alpha-substituted heteroarylalkyl phosphonate derivatives PHAN HIEU T (CH) 2005-06-09 US disclosed
EP-1482953-A1 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES Ilex Products, Inc. (US) 2004-12-08 EP disclosed
WO-2003068240-A1 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES ILEX PRODUCTS, INC. (US) 2003-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124581-A1 Alpha-substituted heteroarylalkyl phosphonate derivatives APOB, APOL1, LDLR POLB 1364/4885LMNA 276/4885SMN1; SMN2 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.